<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">198</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2016-11-2-52-59</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>INVITATION TO DISCUSS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ПРИГЛАШЕНИЕ К ОБСУЖДЕНИЮ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Theory and practice of clinical trials in oncology and hematology</article-title><trans-title-group xml:lang="ru"><trans-title>Теория и практика клинических исследований в онкологии и гематологии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhukov</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Жуков</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>1cancerdoctor1@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogachev</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный научно-клинический центр детской гематологии, онкологии и иммунологии имени Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">1 Samory Mashela str., Moscow, 117997, Russia</institution></aff><aff><institution xml:lang="ru">Россия, 117997, Москва, ул. Саморы Машела, 1</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО «Российский национальный исследовательский медицинский университет им. Н. И. Пирогова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">1 Ostrovitianov str., Moscow, 117997, Russia</institution></aff><aff><institution xml:lang="ru">Россия, 117997, Москва, ул. Островитянова, 1</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-08-05" publication-format="electronic"><day>05</day><month>08</month><year>2016</year></pub-date><volume>11</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>52</fpage><lpage>59</lpage><history><date date-type="received" iso-8601-date="2016-08-05"><day>05</day><month>08</month><year>2016</year></date><date date-type="accepted" iso-8601-date="2016-08-05"><day>05</day><month>08</month><year>2016</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/198">https://oncohematology.abvpress.ru/ongm/article/view/198</self-uri><abstract xml:lang="en"><p>In the era of evidence-based medicine the main reason for the implementation of new treatment methods are the results of clinical trials. However, clinical trials is a separate area of knowledge, which is often little known to clinicians, that does not allow them to adequately interpret the results of studies. The article describes the basic principles for the conduct and interpretation of clinical trials in hematology and oncology.</p></abstract><trans-abstract xml:lang="ru"><p>В эпоху доказательной медицины основным поводом для адаптации новых методов лечения являются результаты клинических исследований. Однако проведение клинических исследований давно превратились в отдельную область знаний, зачастую малоизвестную клиницистам, что не позволяет им адекватно интерпретировать результаты исследований. В статье изложены основные принципы проведения и интерпретации клинических исследований в гематологии и онкологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>clinical studies</kwd><kwd>oncology</kwd><kwd>hematology</kwd><kwd>clinical trial phase</kwd><kwd>statistical significance</kwd><kwd>statistical power</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>клинические исследования</kwd><kwd>онкология</kwd><kwd>гематология</kwd><kwd>фазы клинических исследований</kwd><kwd>статистическая значимость</kwd><kwd>статистическая сила</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Friedman L. M., Furberg C. D., DeMets D. L. Fundamentals of Clinical Trials, 4th ed. 2010. New York, NY: Springer Science + Business Media, LLC.</mixed-citation><mixed-citation xml:lang="ru">Friedman L. M., Furberg C. D., DeMets D. L. Fundamentals of Clinical Trials, 4th ed. 2010. New York, NY: Springer Science + Business Media, LLC.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Streiner D. L., Norman G. R. Drug Trial Phases. Community Oncology. 2009;6(1): 36–40.</mixed-citation><mixed-citation xml:lang="ru">Streiner D. L., Norman G. R. Drug Trial Phases. Community Oncology. 2009;6(1): 36–40.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Наглядная медицинская статистика: учеб. пособие. А. Петри, К. Сэбин; пер. с англ. под ред. В. П. Леонова. 3-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2015. 216 с.</mixed-citation><mixed-citation xml:lang="ru">Наглядная медицинская статистика: учеб. пособие. А. Петри, К. Сэбин; пер. с англ. под ред. В. П. Леонова. 3-е изд., перераб. и доп. М.: ГЭОТАР-Медиа, 2015. 216 с.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Including Clinical Trials in Your Practice – National Cancer Institute, http://www. cancer.gov/resources-for/hp/education/including-clinical-trials-course. pdf</mixed-citation><mixed-citation xml:lang="ru">Including Clinical Trials in Your Practice – National Cancer Institute, http://www. cancer.gov/resources-for/hp/education/including-clinical-trials-course. pdf</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Schilsky Richard L. Oncology Clinical Trials: Successful Design, Conduct and Analysis. Ed. Susan Halabi. Demos Medical Publishing, 2009.</mixed-citation><mixed-citation xml:lang="ru">Schilsky Richard L. Oncology Clinical Trials: Successful Design, Conduct and Analysis. Ed. Susan Halabi. Demos Medical Publishing, 2009.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Guideline on Evaluation of Anticancer Medicinal Products in Man (рекомендации Европейского медицинского агентства, EMA), http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/01/ WC500137128. pdf.</mixed-citation><mixed-citation xml:lang="ru">Guideline on Evaluation of Anticancer Medicinal Products in Man (рекомендации Европейского медицинского агентства, EMA), http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/01/ WC500137128. pdf.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
